Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ependymal tumors.

Timothy J Moynihan¹

¹Department of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. moynihan.timothy@mayo.edu

Current Treatment Options in Oncology

|October 31, 2003

Summary

Ependymal tumors are rare cancers affecting the central nervous system. Current treatments like surgery and radiation have limitations, highlighting the need for novel therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2021

Same author

Resurrecting the Hospital Autopsy: Impact of an Office of Decedent Affairs on Consent Rates, Providers, and Next-of-Kin.

Archives of pathology & laboratory medicine·2020

Same author

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.

Clinical breast cancer·2019

Same author

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2019

Same author

Pathology, imaging, and treatment of cardiac tumours.

Nature reviews. Cardiology·2017

Same author

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline <i>BRCA1</i>- or <i>BRCA2</i>-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017

Area of Science:

Neuro-oncology
Pediatric oncology
Neurosurgery

Background:

Ependymal tumors are rare malignancies originating from ependymal cells lining the brain ventricles and spinal cord's central canal.
While more prevalent in children, adults can also develop these tumors, with prognosis influenced by location, histology, and disease stage.

Purpose of the Study:

To review the current understanding of ependymal tumors, including their characteristics, treatment modalities, and outcomes.
To identify challenges in current treatment paradigms and emphasize the need for innovative therapeutic approaches.

Main Methods:

Comprehensive literature review of ependymal tumor research.
Analysis of prognostic factors, standard treatment protocols, and emerging strategies.

Main Results:

Complete surgical resection is the primary treatment, but local recurrence remains a significant challenge.
The role of adjuvant radiotherapy is debated, particularly in cases of complete resection, with local control being a major obstacle.
Chemotherapy has limited efficacy in the adjuvant setting but may offer benefits for recurrent disease in select cases, especially in young children.

Conclusions:

Current treatment strategies for ependymal tumors face limitations in achieving long-term local control.
Further research and development of novel therapies are crucial to improve outcomes for patients with these rare CNS malignancies.

Related Experiment Videos